World Scientific
Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×
Spring Sale: Get 35% off with a min. purchase of 2 titles. Use code SPRING35. Valid till 31st Mar 2025.

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.
https://doi.org/10.1142/9789813236318_0022Cited by:0 (Source: Crossref)
Abstract:

Percutaneous image-guided ablative therapy is a minimally invasive treatment for primary or secondary malignancies of the lung. This treatment option is especially useful for patients who cannot undergo surgery due to comorbidities or limited pulmonary reserve. Because most ablative procedures can be performed under conscious sedation and in the outpatient setting, patients can recover and be discharged sooner than if they underwent surgery. Current modalities include radiofrequency ablation (RFA), microwave ablation (MWA), and cryoablation. Treatments can be effective with palliating symptoms, increasing survival, and even potentially curing thoracic malignancies.